Article Information
History
- August 14, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Veronica Rendo1,2,3,4,5,#,*,
- Eudocia Q. Lee1,3,6,#,*,
- Connor Bossi8,
- Nicholas Khuu1,2,4,
- Michelle A. Rudek7,
- Sangita Pal1,2,3,4,
- Abigail R. N. Reynolds1,2,4,
- Auriole C.R. Fassinou1,2,4,
- Georges Ayoub8,
- Emily Lapinskas8,
- William Pisano8,
- John Jeang4,
- Sylwia A. Stopka9,
- Michael S. Regan9,
- Johan Spetz10,
- Arati Desai11,
- Frank Lieberman12,
- Joy D. Fisher7,
- Kristine Pelton8,
- Raymond Y. Huang9,
- Louis B. Nabors14,
- Matthias Holdhoff7,
- Neeraja Danda15,
- Roy Strowd16,
- Serena Desideri7,
- Tobias Walbert17,
- Xiaobu Ye7,
- Nathalie Y. R. Agar10,
- Stuart A. Grossman7,
- Brian M. Alexander18,
- Patrick Y. Wen1,3,6,†,
- Keith L. Ligon4,8,19,20,† and
- Rameen Beroukhim1,2,3,4,6,†
- 1Department of Medical Oncology and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 2Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA
- 3Harvard Medical School, Boston, MA, USA
- 4Broad Institute of Harvard and MIT, Cambridge, MA, USA
- 5Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
- 6Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
- 7The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 8Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA
- 9Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 10Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 11Department of Medical Radiation Sciences, Sahlgrenska Cancer Center, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- 12Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- 13Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
- 14Department of Neurology, The University of Alabama at Birmingham, AL, USA
- 15Division of Hematology, Departments of Medicine and Oncology, Montefiore Medical Center, New York, NY, USA
- 16Department of Neurology, Wake Forest University, NC, USA
- 17Department of Neurology and Neurosurgery Henry Ford Health, Department of Neurology, Wayne State, University and Michigan State University, Detroit, MI, USA
- 18Department of Radiation Oncology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 19Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
- 20Department of Pathology, Boston Children’s Hospital, Boston, MA, USA
- ↵*Corresponding authors; email: vrendo{at}gmail.com
Posted August 14, 2024.
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma
